7/9/2014 7:23:48 AM
Les Laboratoires Servier and five makers of generic drugs, including Teva Pharmaceutical Industries Ltd. (TEVA), were fined 427.7 million euros ($582.2 million) by the European Union over agreements that delayed the release of cheaper versions of a hypertension treatment.
Servier, the inventor of the drug, received the largest penalty -- 331 million euros -- for hampering the generic entry of perindopril. Teva was fined 15.6 million euros.
Help employers find you! Check out all the jobs and post your resume.
comments powered by